Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell TransplantationYago Nieto, Roy B. Jones, Elizabeth J. Shpall et al.|Journal of Clinical Oncology|2000Cited by 62